BUY Abbott India Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)8 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·3 Sept · 2mo ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·21 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Abbott India
- BUY — Prakash Gaba15 Sept 2026 · ~2 weeks · target ₹26,500 · SL hit
- BUY — BOB Capital Markets3 Sept 2026 · ~1 year · target ₹30,839 · Active
- BUY — Ansh Jogendra Bhilwar13 Aug 2026 · ~3 months · target ₹30,950 · SL hit
- BUY — BOB Capital Markets13 May 2026 · ~1 year · target ₹36,457 · Active
- BUY — ICICI Securities12 May 2026 · ~1 year · target ₹32,400 · Active
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

